-
Uncategorized2 weeks ago
Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape
Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 billion the year prior. Here’s where all...
-
Fierce Biotech2 weeks ago
Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China
Novo Nordisk and its Chinese partner have reported another midphase win for their triple G candidate, sharing diabetes data to add to the momentum generated by...
-
Uncategorized2 weeks ago
Trace Unites ALS Teams Behind a Target That Could Broaden Treatment Access
Trace Neuroscience, a member of BioSpace’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims to bring more treatment options to...
-
Fierce Biotech2 weeks ago
BrightGene’s oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data
China’s BrightGene has served up a slice of early-stage data to remind everyone that it has a horse in the oral obesity race.
-
STAT News – Biotech2 weeks agoFederal vaccine adviser departs ACIP
WASHINGTON — Robert Malone, an outspoken medical doctor and ally of health secretary Robert F. Kennedy Jr., is stepping away from a panel of federal vaccine...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Sanofi Steps Up Autoimmune Push with Up-to-$1.23B+ Kali Collaboration
Sanofi has agreed to license from Kali Therapeutics its lead tri-specific T-cell engager (TCE) antibody candidate KT501, which is being developed to treat a variety of...
-
AI & Machine Learning in Biotechnology2 weeks agoOpinion: We’re launching a new CMS pilot program to help children with complex conditions
Our public health programs are failing the children who need them most. Together, Medicaid and the Children’s Health Insurance Program (CHIP) cover half of all children...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access
The Federal Trade Commission reached a proposed settlement with CVS Caremark, one of the largest pharmacy benefit managers in the U.S., over allegations the company artificially...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Immunotherapy for Solid Tumors Enhanced by Metabolite-Sensing Receptors
In a new study published in Nature Immunology titled, “Engineering NK and T cells with metabolite-sensing receptors to target solid tumors”, researchers from Stanford University have developed an approach...
-
Uncategorized2 weeks ago
Rezolute Lauds ‘Unusual’ FDA Feedback Supportive of Path Forward for Hypoglycemia Drug
While ersodetug missed the Phase 3 primary endpoint of a reduction in hypoglycemia events, Rezolute argued that this goal was confounded in part by behavioral factors....
